Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference24 articles.
1. Association of dapagliflozin use with clinical outcomes and the introduction of uric acid-lowering therapy and colchicine in patients with heart failure with and without gout: a patient-level pooled meta-analysis of DAPA-HF and DELIVER;Butt;JAMA Cardiol,2023
2. Serum uric acid and diabetes: from pathophysiology to cardiovascular disease;Katsiki;Curr Pharm Des,2021
3. Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: possible molecular pathways;Yaribeygi;J Cell Physiol,2018
4. Sodium-glucose cotransporter 2 inhibitors (SGLT2i): their role in cardiometabolic risk management;Katsiki;Curr Pharm Des,2017
5. Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial;Fitchett;ESC Heart Fail,2021
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Bempedoic Acid in Patients with High Cardiovascular Risk: An Update;Current Vascular Pharmacology;2024-07
2. Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study;Metabolites;2024-06-07
3. Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review;Pediatric Drugs;2024-04-18
4. Sodium–Glucose Cotransporter Protein 2 Inhibitors: Novel Application for the Treatment of Obesity-Associated Hypertension;Diabetes, Metabolic Syndrome and Obesity;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3